What is your preferred second-line therapy for metastatic pancreatic cancer after progression on gemcitabine/nab-paclitaxel who are not candidates for mFOLFIRINOX?
Community PollStarted
What is your preferred second-line therapy for metastatic pancreatic cancer after progression on gemcitabine/nab-paclitaxel who are not candidates for mFOLFIRINOX?
62 physicians have voted
Join Mednetto vote and see how they answered.